Bivalirudin (Angiox) for acute coronary syndromes: SMC review

The Scottish Medicines Consortium issued on 7th December, 2008 an advice on bivalirudin (Angiox): Bivalirudin  (Angiox)  is accepted  for  restricted use within NHS Scotland  for  the  treatment of adult patients with acute coronary syndromes (unstable angina/non-ST segment elevation myocardial  infarction)  planned  for  urgent  or  early  intervention. It  is  restricted  to  use  in patients  who  would  […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos